LOS ANGELES , Dec. 8, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against  DeFi Technologies Inc. ("DeFi " or "the Company") (NASDAQ: DEFT ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of DEFT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

LOS ANGELES , Dec. 8, 2025 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Blue Owl Capital Inc. ("Blue Owl" or "the Company") (NYSE: OWL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2025 and November 16, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before February 2, 2026.

Indian drugmaker Dr Reddy's signed an exclusive licensing pact with Australia's Immutep to manufacture, develop and distribute the latter's cancer therapy, the companies said on Monday.

French oil major TotalEnergies said on Monday it agreed to merge its oil assets in the British North Sea with NEO NEXT Energy, a partnership between Spain's Repsol and HitecVision.

Taiwan Semiconductor Manufacturing remains a key player in the AI boom, with an extremely constrained supply, with Scott Bessent mentioning they can meet 7% of US chip demand. Moat remains wide, with growth rates continuing to exceed expectations following clarification of tariff fears, with their expected CAGR expected to come out in the next quarter. Following Softbank's and US investments in Intel, Intel is gaining momentum for its advanced nodes, despite still being behind in technology and forced to play catch-up.

LOS ANGELES , Dec. 8, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against  MoonLake Immunotherapeutics ("MoonLake " or "the Company") (NASDAQ: MLTX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MLTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

British medical products maker Smith & Nephew raised its 2025 free cash flow forecast to around $800 million and unveiled new medium-term targets ahead of its Capital Markets Day Event on Monday.

LOS ANGELES , Dec. 8, 2025 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against StubHub Holdings, Inc. ("StubHub " or "the Company") (NYSE: STUB ) for violations of the federal securities laws. Shareholders who purchased shares of STUB during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

Vancouver, B.C., December 8 , 2025 – Norsemont Mining Inc. (CSE: NOM, OTC: NRRSF, FWB: LXZ1) (“ Norsemont” or the “ Company”) is pleased to announce it is undertaking a CAD$10 million non­brokered private placement of unsecured convertible debenture units of the Company (each, a “ Convertible Debenture Unit ”) with an overallotment of up to 30% of the offering (the “ Offering ”). Each Convertible Debenture Unit is comprised of one convertible debenture in the principal amount of US$1,000 per debenture (each, a “ Convertible Debenture ”), with each Convertible Debenture and all accrued and unpaid interest thereon convertible into common shares of the Company (each, a “ Conversion Share ”) at a conversion price of CAD$0.86 per Conversion Share (the “ Conversion Price ”), and 802 transferable common share purchase warrants (each, a “ Warrant ”), with each Warrant entitling the holder thereof to purchase one common share (a “ Warrant Share ”) at a price of CAD$1.00 per Warrant Share for a period of three years from the closing date of the Offering (the “ Closing Date ”), subject to acceleration rights for both the Convertible Debentures and the Warrants. The Convertible Debentures bear interest at a rate of 5.25% per annum with a maturity date of three years from the Closing Date (the “ Maturity Date ”). Additionally, the Convertible Debentures includes a gold purchase right whereby, upon commercial production and for a period of one year from commercial production, the subscriber may purchase gold from the Company at a fixed price of US$3,000 per ounce, up to the subscription amount of the subscriber. The Company anticipates closing the financing on December 17, 2025, subject to the standard five-day notice period required by the Canadian Securities Exchange (the “ Exchange ”).

LOS ANGELES , Dec. 8, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 16, 2025 and September 12, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before December 8, 2025.